The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Richter's syndrome (RS) in patients with chronic lymphocytic leukemia (CLL) on novel agent therapy.
 
Matthew Steven Davids
Consulting or Advisory Role - Abbvie; Celgene; Genentech; Gilead Sciences; InCyte; Infinity Pharmaceuticals; Janssen; Pharmacyclics; TG Therapeutics
Research Funding - Genentech (Inst); Infinity Pharmaceuticals (Inst); Pharmacyclics (Inst); TG Therapeutics (Inst)
 
Ying Huang
No Relationships to Disclose
 
Kerry Anne Rogers
No Relationships to Disclose
 
Robert Stern
No Relationships to Disclose
 
Jennifer R. Brown
Honoraria - Abbvie; Janssen Oncology
Consulting or Advisory Role - Abbvie; Astellas Pharma; AstraZeneca; Celgene; Gilead Sciences; Infinity Pharmaceuticals; Janssen; Pharmacyclics; Redx Pharma; Roche/Genentech; Sun Pharma
Research Funding - Gilead Sciences
 
Philip A. Thompson
Consulting or Advisory Role - Pharmacyclics
 
Danielle M. Brander
Consulting or Advisory Role - Abbvie; Genentech; Pharmacyclics; Teva
 
Alexey Valeryevich Danilov
Honoraria - Dava Oncology
Consulting or Advisory Role - Pharmacyclics; Piramal Life Science
Research Funding - AstraZeneca; Piramal Life Science; Takeda
 
Chaitra Shankar Ujjani
Consulting or Advisory Role - Amgen; Genentech; Gilead Sciences; Pharmacyclics
Speakers' Bureau - Abbvie
 
Sameer Ashok Parikh
Consulting or Advisory Role - Pharmacyclics
Research Funding - Pharmacyclics
 
Jacqueline Claudia Barrientos
No Relationships to Disclose
 
Constantine Tam
Honoraria - Abbvie; Janssen; Pharmacyclics; Roche
 
Jennifer Ann Woyach
Consulting or Advisory Role - Janssen
Research Funding - Acerta Pharma (Inst); Karyopharm Therapeutics (Inst); MorphoSys (Inst)